← All indications
Sciatica
A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.
Drugs by status
Phase 4 trials (10)
Phase 3 trials (9)
Phase 2 trials (13)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (15)
- Regeneron
- Cephalon
- Sanofi
- Biogen
- Renovis
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Dental and Craniofacial Research (NIDCR)
- United States Army
- Johns Hopkins University
- University of New South Wales
- Medtronic
- Department of Veteran Affairs
- University of Geneva
- St George & Sutherland Medical Research Foundation
- Breath of Life International Pharma Ltd
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (13)
- United States Navy
- Case Western Reserve University
- Jaseng Hospital of Korean Medicine
- Stony Brook University
- Taipei Medical University
- Leiden University
- Bar Ilan University
- Chengdu University of Traditional Chinese Medicines
- Pennsylvania State University
- Landstuhl Regional Medical Center
- Spaarne Gasthuis
- Achmea Healthcare Foundation
- Posthumus Meyjes Fonds